Browse the detailed record of transactions filed by New Enterprise Associates 16, L.P.. Director active across 3 companies, notably Trevi Therapeutics, Inc.. Aggregated, 6 filings have been recorded. Total volume traded: €5m. The latest transaction was disclosed on 24 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.